Our Vision:
To become the most valuable emerging pharmaceutical company in Egypt.

Our Mission:
To provide our customers quality health care solutions in a cost effective manner by developing products and services that satisfy their health requirements.

Establishment
Rameda began operations in 1994 and was established by a group of Gulf investors with the intention of creating one of the largest pharmaceutical operations in the region.
Owners hired V-Konsult of Germany to create a state-of-the art design.
Contracted British Carter Construction company to build the Rameda’s facilities.

Partnership with Alcon
In 1999, Rameda entered into an agreement with Alcon to manufacture – under license - their ophthalmology products. In order to guarantee the quality of their products, Alcon built one of the highest quality eye production facilities in the region at Rameda.

Quality enhancement
Rameda renewed the syrup production to become GMP (Good Manufacturing Practice).

A new Beginning 
In 2011, Compass Capital led a consortium of private equity investors for the acquisition of 100% of Rameda. Compass Capital plans to establish Rameda as a regional leader in the industry.
To execute this strategy Rameda hired a new management team with a proven track record to complement the existing team.

Company has commissioned M+W Group to transform solid dosage and beta lactam areas into GMP. Brining entire facility to compliance.

Pharmaceutical

Rameda Pharmaceuticals

Amr Morsy

Amr Mohamed

Yasmin Kamal

Saied Hamdy

Moustafa Khallaf

Yehia Amr Morsy

Sherif Atteya

Mohamed Hassan

Amgad Elgabri

Ossama Heiba

Mahmoud Fayek

Finance and Human Resources

Sales and Marketing

Pharmacovigilance and Quality Control

Regulatory and Compliance Team

Research and Development Team

Leadership Team

Operations and Production Team

Teams at Rameda Pharmaceuticals